Effect of Oral Consumption of Vitamin D on Uterine Fibroids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Abstract Impaired vitamin D status is highly prevalent among women with UFs. The objective of this first-ever systematic review and meta-analysis was to summarize the effect of vitamin D supplementation on the size of uterine fibroids (UFs). We performed a comprehensive literature search for published randomized controlled trials (RCTs) in Medline, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials from inception to September 2022. Five trials including 511 participants (256 cases and 255 controls) were included. Pooling results from five trials, which compared size of UFs between experimental and placebo groups, revealed that vitamin D supplementation could significantly decrease the size of UFs (standardized mean difference [SMD]: −0.48, 95% confidence interval [CI]: −0.66, −0.31) and cause improvement in serum level of vitamin D compared to placebo group (SMD: 3.1, 95% CI: 0.66, 5.55). A significant effect was observed in the subset of trials administering vitamin D supplementation for >8 wk (SMD: −0.62, 95% CI: −0.88, −0.37). In conclusion, vitamin D supplementation significantly increases serum levels of vitamin D and reduces the size of UFs. However, larger, well-designed RCTs are still needed to determine the effect of vitamin D on other parameters of UFs.

[1]  G. Udigwe,et al.  Association between serum vitamin D status and uterine leiomyomas: a case-control study , 2023, Obstetrics & gynecology science.

[2]  E. Giovannucci,et al.  The effect of vitamin D on recurrence of uterine fibroids: A randomized, double-blind, placebo-controlled pilot study. , 2022, Complementary therapies in clinical practice.

[3]  B. Moradi,et al.  The Effect of Vitamin D Deficiency on Overgrowth of Uterine Fibroids: A Blinded Randomized Clinical Trial , 2021, International journal of fertility & sterility.

[4]  Ashli M. Molinero,et al.  Children with disabilities in the United States and the COVID-19 pandemic. , 2020, Journal of pediatric rehabilitation medicine.

[5]  A. Al-Hendy,et al.  The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids , 2020, Reproductive Sciences.

[6]  R. Tabrizi,et al.  Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis , 2020, Reproductive Biology and Endocrinology.

[7]  A. Al-Hendy,et al.  Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance , 2020, International journal of molecular sciences.

[8]  F. Darsareh,et al.  Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial. , 2020, Complementary therapies in clinical practice.

[9]  D. Thickett,et al.  Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition. , 2020, Biochemical pharmacology.

[10]  E. Myers,et al.  Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. , 2020, Fertility and sterility.

[11]  S. As-Sanie,et al.  Epidemiology and management of uterine fibroids , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  C. Tribioli,et al.  Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation. , 2020, Current cancer drug targets.

[13]  Qiwei Yang,et al.  Uterine fibroids in menopause and perimenopause. , 2019, Menopause.

[14]  B. Eslami,et al.  The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency , 2019, Caspian journal of internal medicine.

[15]  C. Tamone,et al.  Vitamin D: Nutrient, Hormone, and Immunomodulator , 2018, Nutrients.

[16]  A. Al-Hendy,et al.  Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. , 2018, Journal of women's health.

[17]  Yanfu Sun,et al.  Modulation of VDR and Cell Cycle-Related Proteins by Vitamin D in Normal Pancreatic Cells and Poorly Differentiated Metastatic Pancreatic Cancer Cells , 2018, Nutrition and cancer.

[18]  Qiwei Yang,et al.  Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment , 2018, Acta Pharmacologica Sinica.

[19]  M. Mirmohammadkhani,et al.  Is Vitamin D Effective in the Treatment of Uterine Leiomyoma? A Randomized Controlled Double-Blind Clinical Trial , 2018, Middle East Journal of Rehabilitation and Health.

[20]  H. Abou-Taleb,et al.  Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes. , 2018, European journal of obstetrics, gynecology, and reproductive biology.

[21]  M. Umar,et al.  Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies , 2018, International journal of molecular sciences.

[22]  Sang-Min Jeon,et al.  Exploring vitamin D metabolism and function in cancer , 2018, Experimental & Molecular Medicine.

[23]  S. Wölfl,et al.  Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy , 2017, International journal of molecular sciences.

[24]  M. Martinho,et al.  Update on medical treatment of uterine fibroids. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[25]  H. Hakonarson,et al.  CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations , 2017, The Journal of clinical endocrinology and metabolism.

[26]  P. Conti,et al.  Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. , 2017, Clinical therapeutics.

[27]  J. Klawitter,et al.  Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells , 2017, Proceedings of the National Academy of Sciences.

[28]  F. Reis,et al.  Hormones and pathogenesis of uterine fibroids. , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[29]  P. Leppert.  Faculty Opinions recommendation of 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. , 2015 .

[30]  A. El-Sohemy,et al.  1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. , 2015, The Journal of clinical endocrinology and metabolism.

[31]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[32]  A. Al-Hendy,et al.  Paricalcitol, a Vitamin D Receptor Activator, Inhibits Tumor Formation in a Murine Model of Uterine Fibroids , 2014, Reproductive Sciences.

[33]  D. Bikle.  Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.

[34]  K. Osteen,et al.  1,25-Dihydroxyvitamin D3 Reduces Extracellular Matrix-Associated Protein Expression in Human Uterine Fibroid Cells1 , 2013, Biology of reproduction.

[35]  Md Soriful Islam,et al.  Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction , 2013, Obstetrics and gynecology international.

[36]  L. Fedele,et al.  Vitamin D status in women with uterine leiomyomas. , 2013, The Journal of clinical endocrinology and metabolism.

[37]  D. Baird,et al.  Vitamin D and the Risk of Uterine Fibroids , 2013, Epidemiology.

[38]  Abena B. Redwood,et al.  A new pathway that regulates 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair , 2011, The EMBO journal.

[39]  M. Haussler,et al.  Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[40]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[41]  D. Feldman,et al.  Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[42]  Salahuddin Ahmed,et al.  Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  A. Weissman,et al.  A refined HPLC method to measure catecholamine-o-methyltransferase activity in selected brain regions , 2005, Journal of Neuroscience Methods.

[44]  T. Peng,et al.  Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients. , 2001, Chinese medical journal.

[45]  J. Martinou,et al.  The Bcl-2 protein family. , 2000, Experimental cell research.

[46]  A. Al-Hendy,et al.  Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. , 2011, Fertility and sterility.

[47]  T. McDonnell,et al.  Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.

[48]  N. Weigel,et al.  Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. , 2000, Endocrinology.